No Data
No Data
Merck Buys $50 Million of Personalis Stock
Express News | Personalis Signs Multi-Year Extension With Moderna To Utilize Its ImmunoID NeXT Platform And Technology For V940/mRNA-4157
Express News | Personalis Inc: Merck Has Agreed to Purchase $50 Mln of Personalis Common Stock in a Private Placement at a Price of $3.56 per Share
Personalis Advances Business Strategy With Investment From Merck and Extends Collaboration With Moderna
Cathie Wood's ARK Investment Bought 358.6K Shares of Personalis Today
Tempus AI, Inc (TEM) Expands Partnership With Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma
No Data